Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 24, 2026
Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target

Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target

Key Takeaways

  • The selected price target is $11 per share, the highest current analyst target and a level just above the stock's 52-week high of $10.05.
  • Butterfly Network has delivered record quarterly revenue, raised its full-year guidance, and holds a "Strong Buy" consensus, the strongest bullish factors supporting further upside.
  • The company remains unprofitable with high research and development spending, a key obstacle to sustained appreciation.
  • The $10.05 level represents a critical resistance zone that would need to be cleared before $11 becomes attainable.
  • The key takeaway: reaching $11 is plausible but depends on continued revenue growth and execution rather than on momentum alone.

Why This Price Level Stands Out

Butterfly Network, Inc. (BFLY) develops handheld ultrasound systems built on proprietary ultrasound-on-chip technology. Its point-of-care devices focus on portability and affordability for clinicians. Recent expansions include software and platform offerings such as the Butterfly Embedded program and the Butterfly Garden AI marketplace.

The $11 target matters because it sits just above the 52-week high of $10.05 and aligns with the most bullish analyst forecast. It also represents a roughly 15% gain from recent levels near $9.50, offering a clear benchmark without appearing overly distant.

Current Market Position

The stock has recovered sharply from its 52-week low of $1.34, driven by improved sentiment around the platform transition and better fundamentals. In the second quarter, Butterfly Network posted record revenue of approximately $32.6 million and raised its full-year 2026 outlook to a range of roughly $119 million to $123 million. Analysts project continued double-digit revenue growth into 2027.

Wall Street’s consensus rating stands at “Strong Buy,” with average 12-month price targets ranging from $9.31 to $10.50 depending on the source. Individual targets span from about $5.25 on the low side to $11 on the high end, highlighting differing views on the pace of scaling and profitability.

Potential Drivers for Further Gains

Several developments could support a move toward $11. A co-development and licensing agreement with Midjourney delivered a $15 million upfront fee plus ongoing annual license revenue, adding a software-style income stream. Management has emphasized Butterfly Embedded for integration into third-party devices and the Butterfly Garden ecosystem for partner-developed, FDA-cleared AI applications.

Government opportunities via FedRAMP certification could open doors with agencies such as the Department of Veterans Affairs. The Home & Community Care initiative, aimed at at-home monitoring for conditions like congestive heart failure, offers another long-term avenue. Sustained revenue beats and progress on these newer segments would provide the fundamental backing needed for higher prices. I also checked comparable setups using Tickeron’s AI Screener to see how the stock stacks up against peers.

Obstacles That Could Limit Upside

Profitability remains the primary challenge. Butterfly Network continues to report net losses and negative earnings per share, with elevated research and development costs pressuring results. Because the stock trades mainly on growth expectations, any revenue slowdown, delayed enterprise deals, or guidance miss could weigh on the valuation.

Some independent models suggest the shares trade modestly above estimated fair value, implying that optimistic scenarios may already be priced in. The spread in analyst targets reflects this uncertainty, with several firms maintaining targets of $6 or lower.

Key Technical Levels to Watch

From a technical standpoint, the $10.05 area serves as the main resistance level. A decisive break above it would be necessary for the $11 target to come into realistic reach. On the downside, the $9 psychological level and the broader $8 zone have acted as support where buyers have stepped in previously. Holding above $9 would help maintain the longer-term recovery trend.

Monitoring Momentum with AI Signals

In my analysis of BFLY and similar names, I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to track shifting momentum across thousands of stocks and ETFs. The tool applies artificial intelligence to market conditions and technical behavior, delivering Buy, Sell, or Hold signals that help identify emerging trends without constant manual chart review.

Final Assessment

A move to $11 for Butterfly Network looks ambitious yet attainable given the stock’s position only about 15% below that level, its Strong Buy consensus, record revenue, raised guidance, and expanding platform strategy. These elements provide legitimate support for further appreciation.

That said, the path is not guaranteed. The company is still unprofitable, valuation appears elevated to some models, and the stock must first clear the $10.05 resistance. Investors should track quarterly revenue growth, movement toward profitability, commercialization of the Embedded and Garden platforms, and whether prices hold above key support zones. Reaching $11 will likely hinge on steady execution across these areas.

Using Tickeron for Ongoing Research

Traders looking to follow BFLY alongside other opportunities can explore Tickeron’s AI Daily Buy/Sell Signals for structured, AI-driven insights into momentum and trend shifts. I find it helpful for staying objective when evaluating resistance levels and entry points.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BFLY

BFLY in upward trend: price rose above 50-day moving average on September 21, 2026

BFLY moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 43 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 17, 2026. You may want to consider a long position or call options on BFLY as a result. In 71 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for BFLY just turned positive on September 21, 2026. Looking at past instances where BFLY's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Following a +6.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 186 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

BFLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for BFLY crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for BFLY entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.074) is normal, around the industry mean (10.643). P/E Ratio (0.000) is within average values for comparable stocks, (100.549). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.062). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (16.556) is also within normal values, averaging (39.536).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.55B. The market cap for tickers in the group ranges from 837 to 177.55B. ABT holds the highest valuation in this group at 177.55B. The lowest valued company is DHAI at 837.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 5%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 0%. AEMD experienced the highest price growth at 310%, while FEED experienced the biggest fall at -69%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -61%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 74
Price Growth Rating: 62
SMR Rating: 89
Profit Risk Rating: 95
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
BFLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
1600 District Avenue
Phone
+1 781 557-4800
Employees
220
Web
https://www.butterflynetwork.com
Interact to see
Advertisement
AngloGold Ashanti (AU) shares are tumbling approximately 11% in premarket trading on March 19, 2026, extending a steep multi-week correction that has now erased more than 35% of the stock's value from its March 2 peak of $129.14. The primary sustained catalyst driving the decline is AngloGold's lowered 2026 production guidance, projecting gold output of 2.80–3.17 million ounces — a mid-point decline versus the company's 2025 output of approximately 3.1 million ounces, and below analyst expectations.
CSIQ shares tumbled approximately 18% in premarket trading on March 19, 2026, following the release of deeply disappointing Q4 2025 earnings before the open. The company reported a net loss of $1.66 per diluted share, far worse than the Wall Street consensus estimate of -$0.98, representing a 69% earnings miss.
YRD shares are tumbling approximately 17% in premarket trading on March 19, 2026, from a prior close of $3.68 to approximately $3.05, following the company's release of Q4 and full-year 2025 financial results before the U.S. market open. Primary catalyst: A dramatic swing to net loss in Q4 2025. Yiren Digital reported a Q4 net loss of RMB 882.2 million (~USD 126.1 million), compared to net income of RMB 331.4 million in Q4 2024 — a more than $250 million deterioration year-over-year.
Shares of MU are down approximately 6.66% in premarket trading on March 19, 2026, sliding from a prior close of $461.73 to around $431.00. Despite a historic earnings beat — fiscal Q2 2026 revenue of $23.86 billion versus the $19.19 billion consensus, and adjusted EPS of $12.20 against an $8.79 estimate — the stock is experiencing a classic "sell the news" reaction.
NEM is trading approximately 9% lower in Thursday premarket, extending Wednesday's 4.56% session loss, as gold prices collapse following the Federal Reserve's hawkish policy hold. Gold spot prices fell 4.21% to $4,616.42 per ounce on March 19, marking the precious metal's sixth straight session of declines — its longest losing streak since late 2024.
Shares of VG are surging approximately +8% in Thursday's premarket session on March 19, 2026, with the stock trading near $16.04, up from the March 18 closing price of $14.85. The primary catalyst is a continuation of bullish momentum driven by a series of analyst price target upgrades, with Scotiabank most recently raising its target from $9 to $11.
LINC shares surged approximately +16% in premarket trading on March 19, 2026, reaching roughly $45.83 from a prior close of $39.51. Primary catalyst: Lincoln Educational Services is hosting its highly anticipated Investor Day today at its brand-new Nashville, TN campus, with presentations beginning at 10:00 am CT (11:00 am ET), live-streamed to investors globally.
PSLV is trading approximately 12% lower in premarket on March 19, 2026, tracking a violent selloff in silver futures. The Federal Reserve's hawkish hold on March 18 — keeping rates at 3.50%–3.75% while signaling fewer cuts ahead — was the primary macro trigger.
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target